For half of the investment, the company requested state aid (85 million lei), but the request did not fit within the budget limit for the June-July 2022 session.
"We are still waiting for this financing of 200 million lei to be finally approved from government funds, considering the fact that we are the only producer with full Romanian capital. The investment is in a factory of sterile injectable products, sterile solutions, and a factory of sterile topical products. These two factories must also be completed with their own storage and distribution logistics at the national level", said Ioan Nani, the general director of the manufacturer Antibiotice Iaşi.
The company is 53% owned by the Romanian state, through the Ministry of Health, and is the largest producer of medicines with Romanian capital.
In recent years, Antibiotice has invested in the development of its portfolio in the export area, and in the fall of 2022 it wants to open a new production capacity dedicated to ointments and topical products, after an investment of 25 million euros.
